PuraPharm Corp. Ltd. (HK:1498) has released an update.
PuraPharm Corp. Ltd. has announced a proposed capital reduction and subdivision of its shares, aiming to lower the par value of each issued share from US$0.1 to US$0.001. This move is expected to reduce the company’s accumulated losses and potentially create a more attractive stock structure for investors. However, these changes are contingent on certain conditions being met, urging shareholders to proceed with caution.
For further insights into HK:1498 stock, check out TipRanks’ Stock Analysis page.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
